All pCRC cell lines showed a strong Hsp90α/β protein expression above the prognostic cut-off, i.e., >40% Hsp90α/β-positive cancer cells, which was independent from the clinical–pathological characteristics of the cell lines (Table 3). The gene discussed is HSP90AA1; the disease is cancer.